IP Library › Patent Application 11067197
Patent Application
App. No. 11/067,197

Botulinum toxin pharmaceutical composition

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/067,197
Abstract

A botulinum toxin pharmaceutical formulation free of animal derived proteins, comprising a botulinum toxin and a recombinant albumin, suitable for therapeutic administration to a human patient, and methods for treating patients with various diseases and afflictions with the formulation.

Claims (8)

1 - 19 . (canceled)

20 . A pharmaceutical composition comprising a botulinum toxin type A complex with a molecular weight of about 300 kD.

21 . A pharmaceutical composition comprising a botulinum toxin type A complex with a molecular weight of about 300 kD, wherein the pharmaceutical composition is substantially free of non-300 kD botulinum toxin type A complexes.

22 . The pharmaceutical composition of claim 21 , wherein the pharmaceutical composition is substantially free of about 900 kD and about 500 kD botulinum toxin complexes.

23 . The pharmaceutical composition of claim 22 , wherein the pharmaceutical composition is essentially free of about 900 kD and about 500 kD botulinum toxin complexes.

24 . The pharmaceutical composition of claim 23 , wherein the pharmaceutical composition is entirely free of about 900 kD and about 500 kD botulinum toxin complexes.

25 . A pharmaceutical composition consisting essentially of botulinum toxin type A complex with a molecular weight of about 300 kD.

26 . A pharmaceutical composition consisting of a botulinum toxin type A complex with a molecular weight of about 300 kD.